Abstract:1 INTRODUCTION We investigate the tradeoff between labeled The classical problem of learning a classification rule and unlabeled sample complexities in learning can be stated as follows: patterns from classes " 1 " and a classification rule for a parametric two-class " 2 " (or " states of nature ") appear with probabilities problem. In the problem considered, a sam-P 1 = P and P2 = 1 – p, respectively; the pattern classes ple of m labeled examples and n unlabeled ex-are represented by feature vectors x in a common N-amples generated from a two-class, N-variate dimensional Euclidean space R N, the patterns of class Gaussian mixture is provided together with " i " distributed according to the class-conditional prob-side information specifying the parametric form ability density fi (x) (i = 1, 2), Labeled pairs (x, y) E of the probability densities. The class means RN x {1,2} are assumed generated according to the fol-and a priori class probabilities are, however, lowing mechanism: a pattern class (or " label ") y e {1,2} unknown parameters. In this framework we is first drawn randomly according to the distribution of use the maximum likelihood estimation method classes {p 1, P2}; a corresponding random feature vector to estimate the unknown parameters and uti-x c RN is then drawn according to the class-conditional lize rates of convergence of uniform strong laws density fv. In the supervised learning scenario, a labeled to determine the tradeoff between error rate m-sample { (xj, y j), 1 < j < m } is acquired by inde-and sample complexity. In particular, we show pendent sampling from the distribution of pairs (x, y). that for the algorithm used, the misclassifi-Using the sample, the objective is to construct a deci-mation probability deviates from the minimal sion rule which when presented with a random pattern Bayes error rate by Cl(N3/5n-' /5) + Cl(e-cm) x drawn from the mixture density where N is the dimension of the feature space, f(x) = plfl (x) + P2f2(x) m is the number of labeled examples, n is the number of unlabeled examples, and c is a pos-produces a label which disagrees with the true class it ive constant. of origin by a probability P~,,O, close to the minimal pB~yw error rate. Formally this learning problem can be formulated in the framework of the Probably Approximately Correct (PAC) learning model (cf. [9, 10]) as follows: Given e …

Pharmacokinetic Properties of A 40 Kda Branched Polyethylene Glycol-Modified Form of Consensus Interferon-Alpha (Peg-Cifn) in Rhesus Monkeys

Hydrophilic Biodegradable Microspheres of Interferon-Alpha and Its Pharmacokinetics in Mice.

Pegylation and Cell Based Bioassay of Human Interferon-Α2b along Its Docking Studies and Effect on Plasma Half-Life.

Study on the Effect of Pegylatied Recombinant Consensus Interferon on Immuno-Function in Mice

Immunogenicity and Toxicokinetics Assessment of the Mono-Pegylated Recombinant Human Interleukin-11 in Cynomolgus Monkeys.

Pharmacokinetics of Peginterferons

Immunogenicity of branched polyethylene glycol modified interferon alpha.

Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics

Preclinical evaluation of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys

Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Chinese Subjects: An Open-Label, Randomized, Parallel-Design Bioavailability Study

Pharmacokinetics of PEG-rhG-CSF and rHSA-hG-CSF in mice determined with ELISA

Preclinical Safety Evaluation of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Rhesus Monkey

In vivo pharmacokinetics and pharmacodynamics of positional isomers of mono-PEGylated recombinant human granulocyte colony stimulating factor in rats

Pharmacokinetic Behavior of PEG-IFNα2b in SD Rats

Pharmacokinetics, pharmacodynamics, and toxicity of a PD-1-targeted IL-15 in cynomolgus monkeys

Pharmacokinetics, excretion, distribution, and metabolism of 60-kDa polyethylene glycol used in BAY 94-9027 in rats and its value for human prediction

Synthesis and Systematic Study on the Effect of Different PEG Units on Stability of PEGylated, Integrin-αvβ6-Specific A20FMDV2 Analogues in Rat Serum and Human Plasma

Learning from a mixture of labeled and unlabeled examples with parametric side information

PEGylation of Human Interferon-Α2b with Modified Amino Acids Increases Circulation Half-Life and Antiproliferative Activity

Physiological and Chemical Characteristics of Recombinant Human Interferon Α2b Modified with Polyethylene Glycol

Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A